MT 975 (-)-β-L-2',3'-Dideoxy-3'-thiacytidine, [5-3H(N)]-
Click here for Typical Certificate of Analysis
|
(3TC, [5-3H(N)]-),
(Lamivudine, [5-3H(N)]-) |
MORpure HPLC
purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram |
Ethanol:water (1:1) solution,
1 mCi/ml |
250 µCi
(9.25 MBq)
$1970 |
> 5 Ci(185 GBq)/mmol |
500 µCi
(18.5 MBq) $2360 |
NextGen V-Vial - shipped on dry ice |
1 mCi (37
MBq)
$3350 |
M.W. 229.26 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
M 1602 (-)-β-L-2',3'-Dideoxy 3'-thiacytidine monophosphate, diammonium salt
Click here for Typical Certificate of Analysis
|
(3TC-MP, diammonium salt), (Lamivudine-MP,
diammonium salt) |
Delivered ≥ 90% pure with dated HPLC UV chromatogram |
Solid |
3 µmol
$1315 |
Screw cap v-vial - shipped on dry ice |
M.W. 343.30 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
MT 1602 (-)-β-L-2',3'-Dideoxy-3'-thiacytidine monophosphate, [3H]-
|
(3TC-MP,
[3H]-), (Lamivudine-MP,
[3H]-) |
Delivered ≥ 90% pure with dated HPLC radiochromatogram |
Ethanol:water (1:1)
solution, 1 mCi/ml |
> 1 Ci(37 GBq)/mmol |
Please
Inquire for Pricing |
NextGen V-Vial - shipped on dry ice |
M.W. 309.24
for free acid |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |
M 395 Lamivudine triphosphate, tetraammonium salt
Click here for Typical Certificate of Analysis
|
(3TC-TP,
tetraammonium salt); ((-)-β-L-2',3'-Dideoxy-3'-thiacytidine
triphosphate, tetraammonium salt) |
Delivered ≥ 93%
pure with dated HPLC UV chromatogram |
Solid |
Please
Inquire for Pricing |
Screw cap v-vial - shipped on dry ice |
M.W. 537.32 |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis,
or data derived from its use to support regulatory filings. |